Gene delivery systems—gene therapy vectors for cystic fibrosis
Authors:
- Dirk SchindelhauerDSDirk Schindelhauer
- Andreas LanerALAndreas Laner
- Torry TuckerTTTorry Tucker
- Zsuzsanna BebokZBZsuzsanna Bebok
- Erik M. SchwiebertESErik M. Schwiebert
- A.Christopher BoydABA.Christopher Boyd
- Bob J. ScholteBSBob J. Scholte
- 31 August 2004
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 3, 203-212
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- A Hemodynamic Response to Intravenous Adenovirus Vector Particles Is Caused by Systemic Kupffer Cell-Mediated Activation of Endothelial CellsHuman Gene Therapy, 2003
- The nuclear pore complex: nucleocytoplasmic transport and beyondNature Reviews Molecular Cell Biology, 2003
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectorsBlood, 2003
- The Nasal Epithelium as a Factory for Systemic Protein DeliveryMolecular Therapy, 2002
- Complement activation by recombinant adenovirusesGene Therapy, 2001
- A multi-domain protein for β1 integrin-targeted DNA deliveryGene Therapy, 2000
- Poxvirus vectors: orphaned and underappreciatedJournal of Clinical Investigation, 2000
- Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cellsHuman Molecular Genetics, 2000
- A yeast artificial chromosome contig encompassing the cystic fibrosis locusGenomics, 1991